Cargando…
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar
BACKGROUND: Infusion-related reactions (IRRs) are the most common adverse event (AE) associated with infusion of rituximab, an anti-CD20 monoclonal antibody. OBJECTIVE: Our objective was to evaluate the impact of dosing/infusion patterns and certain baseline characteristics on IRR occurrence during...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295162/ https://www.ncbi.nlm.nih.gov/pubmed/34152584 http://dx.doi.org/10.1007/s40259-021-00487-6 |